COFCO Biotechnology Co., Ltd. (000930.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap10.69B
Enterprise Value10.6B
P/E Ratio-71.28
PEG Ratio0.17
Price/Sales Ratio0.52
Price/Book Ratio0.85
Enterprise/Revenue0.6
Enterprise/EBITDA26.45

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.01
Operating Margin-0.01
AD

Management Effectiveness

Return On Assets-0.01
Return On Equity-0.01

Income Statement

Revenue17.51B
Revenue/Share9.16
Gross Profit1.46B
EBITDA684.99M
Net Income38.37M
Diluted EPS0.02

Balance Sheet

Total Cash1.82B
Total Cash/Share0.98
Total Debt3.17B
Total Debt/Equity0.31
Current Ratio1.17
Book Value Per Share5.82

Price History

52-Week Change-18.84
52-Week High8.14
52-Week Low4.24
Moving Average 50 Days4.72
Moving Average 200 Days5.88

Statistics

Average Volume17.32M
Shares Outstanding1.86B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.03
Trailing Annual Dividend Yield0.63
Payout Ratio-0.58
Last Split Factor2:1
Last Split DateDecember 07, 2005
AD